Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

First Topaz tricuspid valve implanted in European pivotal study

Summary by Cardiovascular News
TRiCares SAS has announced the first implantation of its Topaz transfemoral tricuspid heart valve replacement system in a pivotal study in Europe. The TRICURE European pivotal study is taking place at sites in Germany, Belgium, France and Switzerland, with additional countries expected to follow. The study will assess the safety and efficacy of Topaz in patients with significant tricuspid regurgitation (TR) who are not candidates for open heart …
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

AalstAalst
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal